00:02You're listening to AI Prism from Seoul Economic Daily.
00:06Samsung just opened applications for 6,000 new hires, with AI and chips leading the list.
00:12Foreign chip equipment makers are offering Korean engineers six-figure salaries just
00:18to keep them from leaving. Celltrion just got FDA approval to advance its biosimilar
00:24of the world's best-selling cancer drug. Mucinsa, Korea's biggest fashion platform,
00:29just filed to go public at a targeted $10 trillion valuation. And the government is
00:34building a national strategy to fight AI-powered crime before it gets worse. It's Tuesday,
00:40September 8th. Let's look at what this means for job seekers and graduates in Korea.
00:45Samsung's hiring push reflects a broader chip supercycle, pulling in record capital investment
00:51across the industry. At the same time, Korean biotech and fashion tech companies are pursuing
00:56global growth and public listings on the strength of years of steady expansion.
01:00And as AI capability advances quickly, the government is racing to keep pace with how
01:06that same technology is being misused for crime. Here's what the numbers show.
01:10Samsung will hire about 6,000 new graduates across 19 affiliates this fall, part of a five-year,
01:1860,000-person hiring plan running through 2030, with AI, chips, and biotech roles prioritized.
01:26Foreign chip equipment makers like LAM Research, Tokyo Electron, and ASML are offering Korean
01:32new hires total compensation packages of $70 million to $100 million, competing directly with
01:39Samsung and SK Hynix for talent. Celltrion's biosimilar of Keytruda cleared a U.S. Phase III trial
01:46design change covering 220 lung cancer patients, while its Darzalex biosimilar advanced to Phase III
01:54in Korea covering 394 patients. Mucinza filed for a preliminary COSPI listing review, targeting
02:01a valuation above $10 trillion after posting 22.5 percent revenue growth to $821.7 billion
02:10in the first half of this year. Deepfake crime cases in Korea jumped from 168 in 2023 to 1,300
02:19last year, prompting the government to build a long-term national strategy against AI-enabled
02:25crime by next year. So what does this mean for you as you plan your next step? Earlier, we said
02:32foreign chip equipment makers are offering Korean new hires six-figure salaries, and here's what that
02:38actually means for you. If you're weighing offers in semiconductors, know that global equipment and
02:44materials firms are now genuinely competing with Samsung and SK Hynix on pay, not just prestige,
02:51so it's worth comparing total compensation carefully rather than defaulting to the biggest name. With
02:57SEMI projecting a shortfall of over 1 million semiconductor specialists worldwide by 2030, including
03:04127,000 in Korea alone, this kind of competition for talent is likely to keep intensifying rather
03:11than easing. What to watch? Samsung's application window opens September 8th through 15th and how the
03:17software and design track evaluations differ from the standard aptitude test. Seltrian's Phase 3 trial
03:25progress for both biosimilars over the coming two years and Mucinza's IPO timeline as it moves through
03:31Korea Exchange's preliminary review process. That's today's AI Prism students and grads. This episode
03:39was produced with AI assistance based on Seoul Economic Daily reporting and reviewed by a human
03:45editor. AI Prism is a WANIFRA award-winning series. We'll be back tomorrow. You've been listening to AI Prism
03:51from Seoul Economic Daily.
03:53you
댓글